Supplementary Data from CIP2A is Associated with Human Breast Cancer Aggressivity

Christophe Côme,Anni Laine,Maïa Chanrion,Henrik Edgren,Elina Mattila,Xiaoling Liu,Jos Jonkers,Johanna Ivaska,Jorma Isola,Jean-Marie Darbon,Olli Kallioniemi,Simon Thézenas,Jukka Westermarck

DOI: https://doi.org/10.1158/1078-0432.22440628

2023-01-01

Abstract:Supplementary Data from CIP2A Is Associated with Human Breast Cancer Aggressivity

What problem does this paper attempt to address?

Data from CIP2A is Associated with Human Breast Cancer Aggressivity

Christophe Côme,Anni Laine,Maïa Chanrion,Henrik Edgren,Elina Mattila,Xiaoling Liu,Jos Jonkers,Johanna Ivaska,Jorma Isola,Jean-Marie Darbon,Olli Kallioniemi,Simon Thézenas,Jukka Westermarck

DOI: https://doi.org/10.1158/1078-0432.c.6517930

2023-01-01

Abstract:Abstract Purpose: To investigate the clinical relevance of the recently characterized human oncoprotein cancerous inhibitor of protein phosphatase 2A (CIP2A) in human breast cancer. Experimental Design: CIP2A expression (mRNA and protein) was measured in three different sets of human mammary tumors and compared with clinicopathologic variables. The functional role of CIP2A in breast cancer cells was evaluated by small interfering RNA–mediated depletion of the protein followed by an analysis of cell proliferation, migration, anchorage-independent growth, and xenograft growth. Results: CIP2A mRNA is overexpressed (n = 159) and correlates with higher Scarff-Bloom-Richardson grades (n = 251) in samples from two independent human breast cancer patients. CIP2A protein was found to be overexpressed in 39% of 33 human breast cancer samples. Furthermore, CIP2A mRNA expression positively correlated with lymph node positivity of the patients and with the expression of proliferation markers and p53 mutations in the tumor samples. Moreover, CIP2A protein expression was induced in breast cancer mouse models presenting mammary gland–specific depletion of p53 and either BRCA1 or BRCA2. Functionally, CIP2A depletion was shown to inhibit the expression of its target protein c-Myc. Loss of CIP2A also inhibited anchorage-independent growth in breast cancer cells. Finally, CIP2A was shown to support MDA-MB-231 xenograft growth in nude mice. Conclusions: Our data show that CIP2A is associated with clinical aggressivity in human breast cancer and promotes the malignant growth of breast cancer cells. Thus, these results validate the role of CIP2A as a clinically relevant human oncoprotein and warrant further investigation of CIP2A as a therapeutic target in breast cancer treatment. (Clin Cancer Res 2009;15(16):5092–100)
Cip2a is Associated with Human Breast Cancer Aggressivity

Christophe Come,Anni Laine,Maia Chanrion,Henrik Edgren,Elina Mattila,Xiaoling Liu,Jos Jonkers,Johanna Ivaska,Jorma Isola,Jean-Marie Darbon,Olli Kallioniemi,Simon Thezenas,Jukka Westermarck

DOI: https://doi.org/10.1158/1078-0432.ccr-08-3283

IF: 13.801

2009-01-01

Clinical Cancer Research

Abstract:Purpose: To investigate the clinical relevance of the recently characterized human oncoprotein cancerous inhibitor of protein phosphatase 2A (CIP2A) in human breast cancer.Experimental Design: CIP2A expression (mRNA and protein) was measured in three different sets of human mammary tumors and compared with clinicopathologic variables. The functional role of CIP2A in breast cancer cells was evaluated by small interfering RNA-mediated depletion of the protein followed by an analysis of cell proliferation, migration, anchorage-independent growth, and xenograft growth.Results: CIP2A mRNA is overexpressed (n = 159) and correlates with higher Scarff-Bloom-Richardson grades (n = 251) in samples from two independent human breast cancer patients. CIP2A protein was found to be overexpressed in 39% of 33 human breast cancer samples. Furthermore, CIP2A mRNA expression positively correlated with lymph node positivity of the patients and with the expression of proliferation markers and p53 mutations in the tumor samples. Moreover, CIP2A protein expression was induced in breast cancer mouse models presenting mammary gland-specific depletion of p53 and either BRCA1 or BRCA2. Functionally, CIP2A depletion was shown to inhibit the expression of its target protein c-Myc. Loss of CIP2A also inhibited anchorage-independent growth in breast cancer cells. Finally, CIP2A was shown to support MDA-MB-231 xenograft growth in nude mice.Conclusions: Our data show that CIP2A is associated with clinical aggressivity in human breast cancer and promotes the malignant growth of breast cancer cells. Thus, these results validate the role of CIP2A as a clinically relevant human oncoprotein and warrant further investigation of CIP2A as a therapeutic target in breast cancer treatment. (Clin Cancer Res 2009;15(16):5092-100)
Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Qianying Guo,Hao Wang,Jiahao Duan,Wenwu Luo,Rongrong Zhao,Yuting Shen,Bijun Wang,Siqi Tao,Yi Sun,Qian Ye,Xiaomin Bi,Hui Yuan,Qiang Wu,Peter E. Lobie,Tao Zhu,Sheng Tan,Xing Huang,Zhengsheng Wu

DOI: https://doi.org/10.1158/0008-5472.22432764.v1

2023-01-01

Abstract:Supplementary Data from An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer
Supplementary Data from Pan-Cancer Analysis of Microbiome Quantitative Trait Loci

Can Chen,Yimin Cai,Yizhuo Liu,Shuoni Chen,Yanmin Li,Fuwei Zhang,Ming Zhang,Zequn Lu,Pingting Ying,Jinyu Huang,Linyun Fan,Xiaomin Cai,Caibo Ning,Wenzhuo Wang,Yuan Jiang,Heng Zhang,Shuhui Yang,Zhihua Wang,Xiaoyang Wang,Shaokai Zhang,Chaoqun Huang,Bin Xu,Zhenming Fu,Qibin Song,Mingjuan Jin,Kun Chen,Hongda Chen,Min Dai,Xiaoping Miao,Xiaojun Yang,Ying Zhu,Jianbo Tian

DOI: https://doi.org/10.1158/0008-5472.22432556.v1

2023-01-01

Abstract:Supplementary Data from Pan-Cancer Analysis of Microbiome Quantitative Trait Loci
Supplementary Data File 2 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Arvind S. Mer,Wail Ba-Alawi,Petr Smirnov,Yi X. Wang,Ben Brew,Janosch Ortmann,Ming-Sound Tsao,David W. Cescon,Anna Goldenberg,Benjamin Haibe-Kains

DOI: https://doi.org/10.1158/0008-5472.22421123.v1

2023-01-01

Abstract:Intra-class correlation coefficient (ICC) values for genes across all samples and stratified by tissue type.
Supplementary Data from PAX5α Enhances the Epithelial Behavior of Human Mammary Carcinoma Cells

Laurent J-P Vidal,Jo K. Perry,Cécile M. Vouyovitch,Vijay Pandey,Severine E. Brunet-Dunand,Hichem C. Mertani,Dong-Xu Liu,Peter E. Lobie

DOI: https://doi.org/10.1158/1541-7786.22518459.v1

2023-01-01

Abstract:Supplementary Data from PAX5α Enhances the Epithelial Behavior of Human Mammary Carcinoma Cells
Supplementary data_310718 from Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer

Csilla Sipeky,Ping Gao,Qin Zhang,Liang Wang,Otto Ettala,Kirsi M. Talala,Teuvo L.J. Tammela,Anssi Auvinen,Fredrik Wiklund,Gong-Hong Wei,Johanna Schleutker

DOI: https://doi.org/10.1158/1078-0432.22470675

2023-01-01

Abstract:Supplementary Table 1. Clinical characteristics of Finnish prostate cancer patients Supplementary Table 2. Tumour Stage Group (TSG) definitions Supplementary Table 3. Follow-up characteristics used in survival analyses of Finnish prostate cancer patients Supplementary Table 4. Primer sequences used in quantitative RT-PCR reactions Supplementary Table 5. Assessment of PrCa risk due to the combination of HOXB13 T and CIP2A T in dual carriers relative to the risk in non-carriers Supplementary Table 6 Time-to-PrCa event of HOXB13 rs138213197 and CIP2A rs2278911 Supplementary Table 7 Association of HOXB13 G84E and CIP2A R229Q carrier status and clinical features of prostate cancer subgroups Supplementary Table 8. Association of HOXB13 and CIP2A carrier status and combined modality stage of prostate cancer patients according to ERSPC Supplementary Table 9. P-values for Figure1, Figure 2 and Supplementary figure 2. Supplementary figure 1. Higher mRNA expression pattern of HOXB13-CIP2A correlated with increased risk of prostate cancer biochemical recurrence. Supplementary figure 2. Effects of HOXB13 G84E and CIP2A R229Q variants on prostate cell migration. Supplementary figure 3. ChIP-qPCR in VCaP cell line Supplementary figure 4. Overexpression of HOXB13 G84E and CIP2A R229Q variants promotes cell proliferation.
Immune Infiltration Related CENPI Associates with the Malignant Features and Drug Resistance of Lung Adenocarcinoma.

Ziyang Feng,Guangzu Cui,Jun Tan,Ping Liu,Yihong Chen,Zhaohui Jiang,Ying Han,Shan Zeng,Hong Shen,Changjing Cai

DOI: https://doi.org/10.1016/j.bbadis.2024.167017

2024-01-01

Biochimica et Biophysica Acta - Molecular Basis of Disease

Abstract:Centromere protein I (CENPI) is an important member of centromeric proteins family, which is crucial to chromosome alignment and segregation. Nevertheless, the interrelation between CENPI expression and tumor progression is in the shadows. In this reserch, we carried out a panoramic bioinformatic analysis about CENPI with TCGA, Timer 2.0, Oncomine, GEPIA, Cbioportal, LinkedOmics and CancerSEA databases. Besides, our bioinformatic results have been further confirmed through in vitro experiments, including Real-Time quantitative PCR (RT-qPCR), immunofluorescence (IF), immunohistochemistry (IHC), western blotting (WB), cell proliferation assays, EdU, cell cycle and apoptosis test. Our results suggested that CENPI was increased in most of the cancers, and may serve as a potential biomarker. What's more, the knock down of CENPI inhibited the expression of CDK2 in lung adenocarcinoma (LUAD), and resulted in the arrest of G0/G1 phase and apoptosis. Besides, CENPI was related to immune cells infiltration and drug sensitivity in pan-cancer, and can act as a potential treatment target to cure cancer patients.
Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression

Tianyuan Liu,Xuan Zhao,Yuan Lin,Qi Luo,Shaosen Zhang,Yiyi Xi,Yamei Chen,Lin,Wenyi Fan,Jie Yang,Yuling Ma,Alok K. Maity,Yanyi Huang,Jianbin Wang,Jiang Chang,Dongxin Lin,Andrew E. Teschendorff,Chen Wu

DOI: https://doi.org/10.1158/0008-5472.22431860.v1

2023-01-01

Abstract:Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression
Supplementary Data - Materials and Methods from Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Margarita González-Vallinas,Manuel Rodríguez-Paredes,Marco Albrecht,Carsten Sticht,Damian Stichel,Julian Gutekunst,Adriana Pitea,Steffen Sass,Francisco J. Sánchez-Rivera,Justo Lorenzo-Bermejo,Jennifer Schmitt,Carolina De La Torre,Arne Warth,Fabian J. Theis,Nikola S. Müller,Norbert Gretz,Thomas Muley,Michael Meister,Darjus F. Tschaharganeh,Peter Schirmacher,Franziska Matthäus,Kai Breuhahn

DOI: https://doi.org/10.1158/1541-7786.22517494

2023-01-01

Abstract:Supplementary Data - Materials and Methods
Supplementary Figure 2 from secreted Protein Acidic and Rich in Cysteines-like 1 Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers

Hanguang Hu,Hang Zhang,Weiting Ge,Xiyong Liu,Sofia Loera,Peiguo Chu,Huarong Chen,Jiaping Peng,Lili Zhou,Yu Shibata,Yibin Ying,Suzhan Zhang,Lily Lai,Yun Yen,Shusen Zheng

DOI: https://doi.org/10.1158/1078-0432.22455675

2023-01-01

Abstract:PDF file, 38K, Study design.
Supplementary Data and Methods from ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

Cuicui Liu,Jiankun Qiang,Qiaodan Deng,Jie Xia,Lu Deng,Lei Zhou,Dong Wang,Xueyan He,Ying Liu,Botao Zhao,Jinhui Lv,Zuoren Yu,Qun-Ying Lei,Zhi-Ming Shao,Xiao-Yong Zhang,Lixing Zhang,Suling Liu

DOI: https://doi.org/10.1158/0008-5472.22429821.v1

2023-01-01

Abstract:Supplementary Methods, Figures and Figure legends
Supplementary Data from Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Weiping Peng,Xi Jin,Xiao‐En Xu,Yingju Yang,Ding Ma,Zhi‐Ming Shao,Yi‐Zhou Jiang

DOI: https://doi.org/10.1158/0008-5472.22732543

2023-01-01

Abstract:Supplementary methods, figures, figure legends, and tables
Supplementary Data 2 from Generation of Prostate Tumor–Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling

Yi Qu,Anne Margrete Oyan,Runhui Liu,Yaping Hua,Jigang Zhang,Randi Hovland,Mihaela Popa,Xiaojun Liu,Karl A. Brokstad,Ronald Simon,Anders Molven,Biaoyang Lin,Wei-dong Zhang,Emmet McCormack,Karl-Henning Kalland,Xi-Song Ke

DOI: https://doi.org/10.1158/0008-5472.22398897

2023-01-01

Abstract:XLS file 35K, Chromosomal aberrations of the EPT3-M1.
Supplementary Data from Human Leukocyte Antigen-G Protein Expression is an Unfavorable Prognostic Predictor of Hepatocellular Carcinoma Following Curative Resection

Mingjun Cai,Yongfeng Xu,Shuang‐Jian Qiu,Ju Mei,Qiang Gao,Yiwei Li,Boheng Zhang,Jing Zhou,Jia Fan

DOI: https://doi.org/10.1158/1078-0432.22440222

2023-01-01

Abstract:Supplementary Data from Human Leukocyte Antigen-G Protein Expression Is an Unfavorable Prognostic Predictor of Hepatocellular Carcinoma following Curative Resection
Supplementary Data from Spatial Organization and Prognostic Significance of NK and NKT-like Cells Via Multimarker Analysis of the Colorectal Cancer Microenvironment

Juha P. Väyrynen,Koichiro Haruki,Mai Chan Lau,Sara A. Väyrynen,Tomotaka Ugai,Naohiko Akimoto,Rugang Zhong,Melissa Zhao,Andressa Dias Costa,Jennifer Borowsky,Phoenix Bell,Yasutoshi Takashima,Kenji Fujiyoshi,Κει Arima,Junko Kishikawa,Shanshan Shi,Tyler S. Twombly,Mingyang Song,Kana Wu,Andrew T. Chan,Xuehong Zhang,Charles S. Fuchs,Jeffrey A. Meyerhardt,Marios Giannakis,Shuji Ogino,Jonathan A. Nowak

DOI: https://doi.org/10.1158/2326-6066.22544423.v1

2023-01-01

Abstract:Supplementary Data Supplementary Tables and Figures
Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Gary Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Jia Wang,Shusen Zheng,Yun Yen

DOI: https://doi.org/10.1158/1078-0432.22449236.v1

2023-01-01

Abstract:PDF file 119K, This file includes supplementary text and figure legends for supporting figures
Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Pedro Rocha,Jiexin Zhang,Raquel Laza-Briviesca,Alberto Cruz-Bermúdez,Neus Bota-Rabassedas,Beatriz Sanchez-Espiridon,Kazuhito Funai,Carmen Behrens,Wei Lü,Ximing Tang,Apar Pataer,Edwin R. Parra,Cara Haymaker,Junya Fujimoto,Stephen G. Swisher,John V. Heymach,Don L. Gibbons,John Lee,Boris Sepesi,Tina Cascone,Luisa M. Solis,Mariano Provencio,Ignacio I. Wistuba,Humam Kadara

DOI: https://doi.org/10.1158/1078-0432.22486923

2023-01-01

Abstract:Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC
Supplementary Data URL from an Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Xiaojun Zhao,Cheng Li,J. Guillermo Paez,Koei Chin,Pasi A. Jänne,Tzu-Hsiu Chen,Luc Girard,John Minna,David Christiani,Chris Leo,Joe W. Gray,William R. Sellers,Matthew Meyerson

DOI: https://doi.org/10.1158/0008-5472.22363572

2023-01-01

Abstract:http://research.dfci.harvard.edu/meyersonlab/snp/snp.htm

Supplementary Data from CIP2A is Associated with Human Breast Cancer Aggressivity

Data from CIP2A is Associated with Human Breast Cancer Aggressivity

Cip2a is Associated with Human Breast Cancer Aggressivity

Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Supplementary Data from Pan-Cancer Analysis of Microbiome Quantitative Trait Loci

Supplementary Data File 2 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Data from PAX5α Enhances the Epithelial Behavior of Human Mammary Carcinoma Cells

Supplementary data_310718 from Synergistic Interaction of <i>HOXB13</i> and <i>CIP2A</i> Predisposes to Aggressive Prostate Cancer

Immune Infiltration Related CENPI Associates with the Malignant Features and Drug Resistance of Lung Adenocarcinoma.

Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression

Supplementary Data - Materials and Methods from Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Supplementary Figure 2 from <i>secreted Protein Acidic and Rich in Cysteines-like 1</i> Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers

Supplementary Data and Methods from ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

Supplementary Data from Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Supplementary Data 2 from Generation of Prostate Tumor–Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling

Supplementary Data from Human Leukocyte Antigen-G Protein Expression is an Unfavorable Prognostic Predictor of Hepatocellular Carcinoma Following Curative Resection

Supplementary Data from Spatial Organization and Prognostic Significance of NK and NKT-like Cells Via Multimarker Analysis of the Colorectal Cancer Microenvironment

Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Supplementary Data URL from an Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Supplementary Data from CIP2A is Associated with Human Breast Cancer Aggressivity

Data from CIP2A is Associated with Human Breast Cancer Aggressivity

Cip2a is Associated with Human Breast Cancer Aggressivity

Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Supplementary Data from Pan-Cancer Analysis of Microbiome Quantitative Trait Loci

Supplementary Data File 2 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Data from PAX5α Enhances the Epithelial Behavior of Human Mammary Carcinoma Cells

Supplementary data_310718 from Synergistic Interaction of &lt;i&gt;HOXB13&lt;/i&gt; and &lt;i&gt;CIP2A&lt;/i&gt; Predisposes to Aggressive Prostate Cancer

Immune Infiltration Related CENPI Associates with the Malignant Features and Drug Resistance of Lung Adenocarcinoma.

Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression

Supplementary Data - Materials and Methods from Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Supplementary Figure 2 from &lt;i&gt;secreted Protein Acidic and Rich in Cysteines-like 1&lt;/i&gt; Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers

Supplementary Data and Methods from ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

Supplementary Data from Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Supplementary Data 2 from Generation of Prostate Tumor–Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling

Supplementary Data from Human Leukocyte Antigen-G Protein Expression is an Unfavorable Prognostic Predictor of Hepatocellular Carcinoma Following Curative Resection

Supplementary Data from Spatial Organization and Prognostic Significance of NK and NKT-like Cells Via Multimarker Analysis of the Colorectal Cancer Microenvironment

Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Supplementary Data URL from an Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Supplementary data_310718 from Synergistic Interaction of <i>HOXB13</i> and <i>CIP2A</i> Predisposes to Aggressive Prostate Cancer

Supplementary Figure 2 from <i>secreted Protein Acidic and Rich in Cysteines-like 1</i> Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers